Effects of Sodium Chloride or Its Substitute Salt Potassium Chloride on Vascular Function (ESCAPE-SALT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05970601 |
Recruitment Status :
Not yet recruiting
First Posted : August 1, 2023
Last Update Posted : August 1, 2023
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Vascular Function Healthy Diabetes | Dietary Supplement: Soup | Not Applicable |
Some of the leading death causes in western countries are attributed to artheriosclerosis with its consequences especially cardiovascular events. Beside lifestyle risk factors such as physical inactivity, adipositas and stress, high dietary sodium intake is one of the easiest modifiable factors to reduce development and progession of artheriosclerosis. Unfortunately high sodium diet is one of the hallmarks of western diet. Epidemiologic and experimental data have provided compelling evidence that high salt and its induced elevation in bloodpressure is an important factor in the development and progression of cardiovascular disease, artheriosclerosis with its endorgan failure.
To analyze the reasons for the hazardous effects of high oral sodium chloride exposure on vascular damage and a possible protective mechanism by the salt substitute potassium chloride, we intend to conduct a single-center randomized trial (ESCAPE-SALT). We aim to measure vascular function by flow mediated dilation (FMD) and dynamic vessel analysis (DVA) of retinal mircocirculation. Participants will be divided into 3 groups. Each group will be served a soup with different salt content. The salt composition is as follows: soup A (9 g sodium chloride), soup B (6 g sodium chloride plus 3 g potassium chloride), and soup C (6 g sodium chloride). The effects on blood pressure, body composition markers, electrolytes, inflammatory and metabolic response, and vascular function are measured before, 4 and 24 h after ingestion of the soup. Furthermore we will investigate the underlying mechanism by performing metabolomic, transcriptomic and proteomic anyalysis.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 60 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Basic Science |
Official Title: | Effects of Sodium Chloride or Its Substitute Salt Potassium Chloride on Vascular Function and Immune Response - a Randomized Controlled Trial |
Estimated Study Start Date : | August 1, 2023 |
Estimated Primary Completion Date : | June 2025 |
Estimated Study Completion Date : | October 2026 |
Arm | Intervention/treatment |
---|---|
Experimental: high salt group
Intake of 9 g sodium chloride
|
Dietary Supplement: Soup
Intake of a single soup with different sodium chloride and potassium chloride content |
Active Comparator: low salt group
Intake of 6 g sodium chloride
|
Dietary Supplement: Soup
Intake of a single soup with different sodium chloride and potassium chloride content |
Active Comparator: substitution group
Intake of 6 g sodium chloride plus 3 g potassium chloride
|
Dietary Supplement: Soup
Intake of a single soup with different sodium chloride and potassium chloride content |
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium chloride on retinal vessel diameter and the flicker-light-induced retinal vessel dilatation. [ Time Frame: Baseline, 4 hours, 24 hours ]Flicker-induced dilatation and diameter of fundus vessels will be measured via funduscopy in a static an dynamic analysis before, 4 hours and 24 hours after ingestion of a salty soup and the change between the timepoints will be analyzed. First the diameter of venoles and arterioles in µm and their ratio are measured in a standardized fundus picture. In a second step we will film the fundus during three flicker-light periods of 20 seconds and measure the dilatation in percent during the flicker period.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium chloride on hypoxia-induced dilatation of brachial artery. [ Time Frame: Baseline, 4 hours, 24 hours ]Flow mediated dilatation (FMD) as a marker for macrovascular function will be measured at baseline, 4 hours and 24 hours after ingestion of a salty soup. We will measure FMD by ultrasound based measurement of brachial artery diameter in mm before and after induced hypoxia for 5 minutes. The change of dilatation in percentage between the different timepoints will be analyzed.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium chloride on mitochondrial respiration capacity in PBMC. [ Time Frame: Baseline, 4 hours, 24 hours ]Analysis of mitochondrial respiration capacity via seahorse technology in isolated PBMC from baseline, 4 and 24 hours after salt intake. The oxygen consumption rate (OCR) will be measured and the changes between the timepoints will be analyzed.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium chloride on NO metabolism in serum and red blood cells. [ Time Frame: Baseline, 4 hours, 24 hours ]We will measure the amount of nitrite and nitrate in red blood cells and serum by gas chemiluminescence at baseline, 4 and 24 hours after salt intake. The change between the three timepoints will be measured.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium on metabolic profile in PBMC and plasma. [ Time Frame: Baseline, 4 hours, 24 hours ]We will investigate the effect of a single oral high-sodium chloride load or a partial substitution by potassium on the metabolic profile in PBMCs and theplasma. The metabolites will be measured by liquid chromotagraphy and high resolution tandem mass spectrometry at baseline, 4 hours and 24 hours after salt intake. The difference between the timepoints will be analyzed.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium on systemic inflammation markers. [ Time Frame: Baseline, 4 hours, 24 hours ]Inflammatory markers such as cytokines will be meassured at baseline, 4 and 24 hours after salt intake by ELISA and OLINK. Changes of these markers between the three timepoints will be analyzed.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium chloride on fluid body composition. [ Time Frame: Baseline, 4 hours, 24 hours ]Analysis of fluid body composition and intra- and extracellular water amount by bioimpendance monitoring at baseline, 4 and 24 hours after salt intake. The changes in body composition between the three timepoints will be measured.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium chloride on blood pressure. [ Time Frame: Baseline, 4 hours, 24 hours ]Analysis of blood pressure by automated office blood pressure device at baseline, 4 hours and 24 hours after salt intake. The changes in blood pressure between the three timepoints will be measured.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium chloride on renin-angiotensine-aldosterone system. [ Time Frame: Baseline, 4 hours, 24 hours ]Analysis of renin, angiotensine and aldosterone levels at baseline, 4 hours and 24 hours after salt intake, measurement will be done in the clinical routine laboratory and the difference between timepoints will be analyzed.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium on fecal microbiome. [ Time Frame: up to 48 hours before and after salt intake ]Analysis of the change of fecal microbiome composition in microbiology of probes before and after salt intake.
- Effect of a single oral high-sodium chloride load or a partial substitution by potassium on metabolomics in stool. [ Time Frame: up to 48 hours before and after salt intake ]Analysis of the change of metabolomics in stool and serum after salt intake using liquid chromotagraphy and high resolution tandem mass spectrometry.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- full-aged
- signed informed consent
- no dietary restrictions
- access to retina for microvascular measurement
Exclusion Criteria:
- age <18 y
- no retinal access for microvascular measurement
- known glaucoma
- antibiotic therapy within the last 4 weeks
- immunosuppressive Therapie within the last 4 weeks (e.g. glucocorticoids)
- s.p. malignancy
- unknown fever within the last 4 weeks
- salt wasting syndroms (e.g. renal tubular acidosis, Diabetes insipidus)
- chronic kidney disease stage 4-5
- known electrolyte disorder (e.g. hyperkalaemia, hypokalaemia, hypernatriaemia, hyponatriaema)
- no or rejected informed consent
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05970601
Contact: Johannes Stegbauer, Prof.Dr.med. | +492118117502 | johannes.stegbauer@med.uni-duesseldorf.de | |
Contact: Claudia Schmidt, PhD | +492118108074 | claudia.schmidt@med.uni-duesseldorf.de |
Responsible Party: | Prof. Dr. med. Johannes Stegbauer, Assistant Professor, Heinrich-Heine University, Duesseldorf |
ClinicalTrials.gov Identifier: | NCT05970601 |
Other Study ID Numbers: |
2022-1844 |
First Posted: | August 1, 2023 Key Record Dates |
Last Update Posted: | August 1, 2023 |
Last Verified: | July 2023 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
potassium chloride sodium chloride microcirculation |